PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), based at the Babraham Research Campus, and the Welch research group at ...

CAMBRIDGE, England, February 24, 2026--(BUSINESS WIRE)--BioMed Realty, the largest private operator of real estate for the life science and technology industries, today announced the completion of the ...

Following a quinquennial review by the Biotechnology and Biological Sciences Research Council (BBSRC), the Babraham Institute will receive £48m for the period 2024-2028 to advance research on the ...

Babraham Research Campus Ltd is responsible for the management and commercial development of the Babraham Research Campus. The Babraham Research Campus is distinct in its co‐location of 60 bioscience ...

A new stem cell model, discovered by researchers exploring the human genome, will help scientists to map out the key genomic changes during early development. The finding, made by the Babraham ...

Researchers from the Babraham Institute have today published their latest work in the journal Cell Stem Cell describing a new subset of human embryonic stem cells that closely resemble the cells ...

PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), based at the Babraham Research Campus, and the Flow Cytometry Facility at ...

Scientists at the Babraham Institute have discovered a novel survival factor whose rapid transport along nerve cells is crucial for keeping them alive. The same factor seems likely to be needed to ...

The funding will help to support research across epigenetics, immunology and cell signalling The Biotechnology and Biological Sciences Research Council (BBSRC) has invested £48m into the Babraham ...

A team in the Babraham Institute in Cambridge has successfully rejuvenated a 53-year-old woman's skin cells to look and behave like a 23-year-old's, the research center announced on Thursday. The team ...

Oxford life sciences company MitoRx has opened a lab on the Babraham Research Campus in Cambridge as an additional springboard to global growth with a drug discovery solution designed to fight obesity ...